<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320740">
  <stage>Registered</stage>
  <submitdate>4/11/2009</submitdate>
  <approvaldate>18/11/2010</approvaldate>
  <actrnumber>ACTRN12610001006033</actrnumber>
  <trial_identification>
    <studytitle>Effect of a short post-operative course of oral prednisone on post-operative morbidity following tonsillectomy in children.</studytitle>
    <scientifictitle>Effect of a short post-operative course of oral prednisone versus placebo on post-operative morbidity following tonsillectomy in children.</scientifictitle>
    <utrn>U1111-1112-2853</utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>recovery after tonsillectomy in children</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>five day course of oral prednisolone post tonsillectomy (0.5mg/kg) once daily</interventions>
    <comparator>placebo syrup. sugar syrup with identical flavour to prednisolone and same volume as equivalent paracetamol syrup. For five days post-operatively once daily</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Visual analogue pain scale</outcome>
      <timepoint>2 hours post-operation
8 hours post-operation
days 1-8 post-operation once daily</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nausea as presence or absence</outcome>
      <timepoint>2 hours post-operation
8 hours post-operation
days 1-8 post-operation once daily</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>vomiting - presence or absence of symtpom</outcome>
      <timepoint>2 hours post-operation
8 hours post-operation
days 1-8 post-operation once daily</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>return to normal function (eating, daily activities) - assessed as yes returned to normal function or no not returned to normal function.</outcome>
      <timepoint>2 hours post-operation
8 hours post-operation
days 1-8 post-operation once daily</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>change in behaviour. assessed with subjective questions</outcome>
      <timepoint>2 hours post-operation
8 hours post-operation
days 1-8 post-operation once daily</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>children undergoing tonsilectomy
age 2-16
anaesthetic rating using American Society of Anaesthesiologists standard rating 1 or 2</inclusivecriteria>
    <inclusiveminage>2</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>16</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>bleeding disorder
severe asthma</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>simple randomisation using computer generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>7/10/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>198</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Otago</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Healthcare Otago Charitable trust</primarysponsorname>
    <primarysponsoraddress>Dunedin Public Hospital
Great King Street
Dunedin 9001
New Zealand</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Healthcare Otago Charitable Trust Grant</fundingname>
      <fundingaddress>Dunedin Public Hospital
Great King Street
Dunedin 9001
New Zealand</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of the study is to see if a short course of a steroid mediation given post-operatively improves recovery after tonsillectomy in children. We hypothesize that oral prednisolone may be of benefit as an equivalent intravenous medication given at the time of tonsillectomy has been shown to be of benefit.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Lower South Regional Ethics committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>25/06/2009</ethicapprovaldate>
      <hrec>LRS08/06/024</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Patrick Dawes</name>
      <address>c/o Otolaryngology department
Dunedin Public Hospital
Gt King Street
Dunedin 9001</address>
      <phone>006434740999</phone>
      <fax />
      <email>patrick.dawes@healthotago.co.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Patrick Dawes</name>
      <address>c/o Otolaryngology department
Dunedin Public Hospital
Gt King Street
Dunedin 9001</address>
      <phone>006434740999</phone>
      <fax />
      <email>patrick.dawes@healthotago.co.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Patrick Dawes</name>
      <address>c/o Otolaryngology department
Dunedin Public Hospital
Gt King Street
Dunedin 9001</address>
      <phone>006434740999</phone>
      <fax />
      <email>patrick.dawes@healthotago.co.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>